| |
| |
|
| Insider
Information: |
Scott Randal W |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,371,339 |
|
|
Indirect Shares
|
1,784,829 |
|
|
| Direct
Value |
$75,330,529 |
|
|
|
Indirect Value
|
$1,190,502 |
|
|
| Total
Shares |
3,156,168 |
|
|
| Total
Value |
$76,521,031 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -22.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genomic Health Inc |
GHDX |
CEO, InVitae Corporati... |
2012-07-11 |
1,185,117 |
2012-07-11 |
15,764 |
Premium* |
|
|
Invitae Corp |
NVTA |
Director |
2023-04-27 |
161,222 |
2023-04-27 |
60,000 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
|
2024-03-01 |
5,000 |
2024-03-01 |
6,500 |
Premium* |
|
|
Talis Biomedical Corp |
TLIS |
Director |
2021-05-17 |
20,000 |
2021-05-17 |
1,702,565 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2020-06-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
|
– • – |
2024-03-01 |
4 |
AS |
$34.00 |
$85,000 |
I/I |
(2,500) |
6,500 |
0 |
% |
|
| TLIS |
Talis Biomedical Corp |
Director |
– • – |
2021-05-14 |
4 |
B |
$10.16 |
$91,440 |
D/D |
9,000 |
9,000 |
2.39 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-12-18 |
4 |
AS |
$40.00 |
$80,000 |
I/I |
(2,000) |
9,000 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-12-01 |
4 |
AS |
$28.50 |
$73,500 |
I/I |
(2,500) |
11,000 |
0 |
% |
|
| GHDX |
Genomic Health Inc |
Chairman and CEO |
• • – |
2005-10-04 |
4 |
A |
$0.00 |
$0 |
I/I |
11,820 |
11,820 |
|
- |
|
| GHDX |
Genomic Health Inc |
Chairman and CEO |
• • – |
2005-10-04 |
4 |
A |
$0.00 |
$0 |
I/I |
478 |
12,298 |
|
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-09-05 |
4 |
AS |
$30.00 |
$75,000 |
I/I |
(2,500) |
13,500 |
0 |
% |
|
| TLIS |
Talis Biomedical Corp |
Director |
– • – |
2021-05-17 |
4 |
B |
$10.11 |
$111,210 |
D/D |
11,000 |
20,000 |
2.39 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2021-02-17 |
4 |
B |
$62.50 |
$1,000,000 |
D/D |
16,000 |
21,000 |
2.39 |
% |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2022-07-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
37,000 |
|
% |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2022-07-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
60,000 |
|
% |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2022-07-16 |
4 |
A |
$0.00 |
$0 |
D/D |
53,800 |
90,800 |
0 |
- |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2023-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
70,422 |
161,222 |
0 |
- |
|
| TLIS |
Talis Biomedical Corp |
Director |
– • – |
2021-02-17 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
312,500 |
2.1 |
- |
|
| GHDX |
Genomic Health Inc |
Chairman and CEOOfficer |
• • – |
2005-09-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
595,000 |
|
- |
|
| GHDX |
Genomic Health Inc |
CEO, InVitae Corporation* |
• • – |
2012-07-11 |
4 |
AS |
$34.79 |
$522,134 |
D/D |
(15,000) |
1,185,117 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CEO, InVitae Corporation* |
• • – |
2012-07-10 |
4 |
AS |
$35.96 |
$539,537 |
D/D |
(15,000) |
1,200,117 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CEO, InVitae Corporation* |
• • – |
2012-06-12 |
4 |
AS |
$33.31 |
$499,654 |
D/D |
(15,000) |
1,215,117 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CEO, InVitae Corporation* |
• • – |
2012-06-11 |
4 |
AS |
$33.74 |
$506,562 |
D/D |
(15,000) |
1,230,117 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CEO, InVitae Corporation* |
• • – |
2012-05-11 |
4 |
AS |
$30.00 |
$457,742 |
D/D |
(15,000) |
1,245,117 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CEO, InVitae Corporation* |
• • – |
2012-05-10 |
4 |
AS |
$29.92 |
$448,981 |
D/D |
(15,000) |
1,260,117 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CEO, InVitae Corporation* |
• • – |
2012-04-11 |
4 |
AS |
$28.38 |
$283,790 |
D/D |
(10,000) |
1,275,117 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CEO, InVitae Corporation* |
• • – |
2012-04-10 |
4 |
AS |
$28.75 |
$288,081 |
D/D |
(10,000) |
1,285,117 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CEO, InVitae Corporation |
• • – |
2012-03-13 |
4 |
AS |
$31.12 |
$466,764 |
D/D |
(15,000) |
1,295,117 |
0 |
- |
|
158 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
